NCT04551573 A Study of the Pharmacokinetic and Pharmacodynamic Interactions Between Bictegravir, Tenofovir Alafenamide and Rifapentine in Healthy Adult Subjects Status WITHDRAWN Phase PHASE4
NCT04547738 Influence of Filarial Infections on Tuberculosis Disease and Tuberculosis Vaccination in Cameroon Status UNKNOWN Phase N/A
NCT04545788 Randomized Controlled Multi-center Short Course Treatment for Rifampicin Resistant Tuberculosis Status UNKNOWN Phase NA
NCT04538911 Phase I Clinical Protocol for Pre-evaluation of the Safety of BCG-PPD in Tuberculosis Patients Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT04518228 Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartum Status COMPLETED Phase N/A
NCT04513379 Efficacy of 400 mg Efavirenz Versus Standard 600 mg Dose in HIV/TB Co-infected Patients Status UNKNOWN Phase PHASE3
NCT04493671 Evaluate Safety, Tolerability, PK of TBAJ-876 in Healthy Adults Status COMPLETED Phase PHASE1
NCT04472897 A Study to Evaluate Safety, Tolerability and Pharmacokinetics of GSK2556286 in Healthy Adult Participants Status TERMINATED Phase PHASE1
NCT04443283 The Effect of Latent Tuberculosis Infection on the Pregnancy Outcome of IVF-ET Status UNKNOWN Phase N/A
NCT04424264 The Effect of Rifampicin on the Pharmacokinetics of Intracellular Tenofovir-diphosphate and Tenofovir When Coadministered With Tenofovir Alafenamide Fumarate During the Maintenance Phase of Tuberculosis Treatment in TB/HIV-1 Coinfected Participants Status COMPLETED Phase PHASE1
NCT04325438 The Impact of Pharmacists' Interventions on the Quality of Life of HIV-TB Co-infection Outpatients in Indonesia Status COMPLETED Phase NA
NCT04311502 Clofazimine- and Rifapentine-Containing Treatment Shortening Regimens in Drug-Susceptible Tuberculosis: The CLO-FAST Study Status TERMINATED Phase PHASE2